Effects of the committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK

Drug Safety

Volumn 28, Issue 12, 2005, Pages 1151-1157

  Murray, Macey L ^a   Thompson, Mary ^b   Santosh, Paramala J ^c   Wong, Ian C K ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IQVIA   (United States)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BACKACHE; CALCULATION; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG FORMULARY; DRUG SAFETY; HUMAN; INCIDENCE; MEDICAL RECORD; MEDICAL SOCIETY; MIGRAINE; NEUROPATHIC PAIN; OBSESSIVE COMPULSIVE DISORDER; PEDIATRICS; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADOLESCENT; ADVISORY COMMITTEES; ANTIDEPRESSIVE AGENTS; ANXIETY; CHILD; DEPRESSION; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GREAT BRITAIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE;

EID: 28844509678     PISSN: 01145916     EISSN: 01145916     Source Type: Journal    
DOI: 10.2165/00002018-200528120-00009     Document Type: Article

References (15)

1. Wong ICK, Murray ML, Camilleri-Novak D, et al. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 2004; 89: 1131-2
2. Murray ML, de Vries CS, Wong ICK. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004; 89: 1098-102
3. Committee on Safety of Medicines. Selective serotonin reuptake inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data 2003. Available from URL: http://www.medicines.mhra.gov.uk/ourwork/monitorsafequalmed/ safetymessages/ssrioverview_101203.htm [Accessed 2005 Apr 5]
4. Wong ICK, Besag FMC, Santosh PJ, et al. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Saf 2004; 27 (13): 991-1000
5. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disor-ders in children and adolescents. N Engl J Med 2001; 344: 1279-85
6. Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003; 160: 1919-28
7. Wong IC, Murray ML. Potential of clinical databases for paediatric medication research in the UK. Br J Clin Pharmacol 2005; 59 (6): 750-5
8. Lawrenson RA, Coles G, Walton K, et al. Characteristics of practices contributing to the Mediplus database and the implications for its use in epidemiological research. J Inform Prim Care 1998 May, 18
9. Langman M, Kahler KH, Kong SX, et al. Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom. Pharmacoepidemiol Drug Saf 2001; 10 (6): 517-24
10. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary (September). London: Pharmaceutical Press, 2004: 194-205
11. Prescription statistics publications. Prescriptions dispensed in the community in England. Available from URL: http://www.publications.doh.gov.uk/ prescriptionstatistics/index.htm [Accessed 2005 Jun 13]
12. National Statistics. Population estimates: current releases. Available from URL: http://www.statistics.gov.uk/statbase/ explorer.asp?.CTG = 3&SL = 4819&D = 4819&DCT = 0&DT = 32#4819 [Accessed 2005 Jun 23]
13. Committee on Safety of Medicines. Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants: Annex A - Prescribing trends for SSRIs and related antidepressants 2004. Available from URL: http://www.medicines.mhra.gov.uk/ourwork/ monitorsafequalmed/ safetymessages/Annex%20A.pdf [Ac-cessed 2005 Feb 1]
14. Wong ICK, Novak-Camilleri D, Stephens P. Rise in psychotropic drug prescribing in children in the UK: an urgent public health issue. Drug Saf 2003; 26 (15): 1117-8
15. Kennedy E. Child and adolescent psychotherapy: a systematic review of psychoanalytic approaches. London: North Central London Strategic Health Authority, 2004